AIMS: Angiogenesis in solid tumour pathology is well established but less is known about its role in haematological malignancies. Our study investigated the immunohistochemical expression of a variety of angiogenic and hypoxic factors and microvessel densities on 110 cases of high- and low-grade non-Hodgkin's lymphomas and reactive lymphoid tissues. methods and results: Expression of vascular endothelial growth factor (VEGF) was present in 82 (96%) of the non-Hodgkin's cases and 35 (100%) of the reactive lymphoid tissue cases. Both hypoxia inducible factors 1 alpha and 2 alpha (HIF 1 alpha, 2 alpha) were weakly expressed in the majority of high- and low-grade lymphomas. Carbonic anhydrase IX (CA IX), a HIF-inducible membrane-bound enzyme, expression was not abundant with membranous staining being present in seven (8%) of the lymphoma cases and none of the reactive cases. Thymidine phosphorylase (TP) was distributed amongst macrophages and follicular dendritic cells but was not present in the neoplastic population. The vasculature was stained using CD34 which gave rise to a distinct vascular, predominantly paracortical network present in low-grade lymphomas and reactive lymphoid tissue but which was lost in high-grade lymphomas. CONCLUSION: Our results suggest that non-Hodgkin's lymphomas may be less angiogenic and hypoxically driven than most solid tumours, which has implications for possible future therapies.
AIMS: Angiogenesis in solid tumour pathology is well established but less is known about its role in haematological malignancies. Our study investigated the immunohistochemical expression of a variety of angiogenic and hypoxic factors and microvessel densities on 110 cases of high- and low-grade non-Hodgkin's lymphomas and reactive lymphoid tissues. methods and results: Expression of vascular endothelial growth factor (VEGF) was present in 82 (96%) of the non-Hodgkin's cases and 35 (100%) of the reactive lymphoid tissue cases. Both hypoxia inducible factors 1 alpha and 2 alpha (HIF 1 alpha, 2 alpha) were weakly expressed in the majority of high- and low-grade lymphomas. Carbonic anhydrase IX (CA IX), a HIF-inducible membrane-bound enzyme, expression was not abundant with membranous staining being present in seven (8%) of the lymphoma cases and none of the reactive cases. Thymidine phosphorylase (TP) was distributed amongst macrophages and follicular dendritic cells but was not present in the neoplastic population. The vasculature was stained using CD34 which gave rise to a distinct vascular, predominantly paracortical network present in low-grade lymphomas and reactive lymphoid tissue but which was lost in high-grade lymphomas. CONCLUSION: Our results suggest that non-Hodgkin's lymphomas may be less angiogenic and hypoxically driven than most solid tumours, which has implications for possible future therapies.
Authors: Martin A Proescholdt; Christina Mayer; Marion Kubitza; Thomas Schubert; Shu-Yuan Liao; Eric J Stanbridge; Sergey Ivanov; Edward H Oldfield; Alexander Brawanski; Marsha J Merrill Journal: Neuro Oncol Date: 2005-10 Impact factor: 12.300
Authors: Mari Leppilampi; Tuomo J Karttunen; Jyrki Kivelä; Marta Ortova Gut; Silvia Pastoreková; Jaromir Pastorek; Seppo Parkkila Journal: Transgenic Res Date: 2005-10 Impact factor: 2.788
Authors: Liu Qi Chen; Christine M Howison; Catherine Spier; Alison T Stopeck; Scott W Malm; Mark D Pagel; Amanda F Baker Journal: Leuk Lymphoma Date: 2014-11-10
Authors: Z Gunnur Dikmen; Ginelle C Gellert; Pakize Dogan; Heejeong Yoon; Young Bok Lee; Chang Ho Ahn; Jerry W Shay Journal: J Cell Biochem Date: 2008-06-01 Impact factor: 4.429
Authors: Andrew M Evens; Paul T Schumacker; Irene B Helenowski; Amareshwar T K Singh; Danijela Dokic; Anjeni Keswani; Elizabeth Kordeluk; Adekunle Raji; Jane N Winter; Borko D Jovanovic; Arne Holmgren; Beverly P Nelson; Leo I Gordon Journal: Br J Haematol Date: 2008-04-15 Impact factor: 6.998
Authors: Kristen Ganjoo; Fangxin Hong; Sandra J Horning; Randy D Gascoyne; Yasodha Natkunam; Lode J Swinnen; Thomas M Habermann; Brad S Kahl; Ranjana H Advani Journal: Leuk Lymphoma Date: 2013-07-29